Work

Long-term follow-up of azacitidine, venetoclax, and gilteritinib in patients with newly diagnosed FLT3-mutated Acute Myeloid Leukemia

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-45

Authors: Roberta S. Azevedo, Naval Daver, Omer Karrar, Courtney DiNardo, Tapan Kadia, Musa Yilmaz, Gautam Borthakur, Ghayas Issa, Elias Jabbour, Xuelin Huang, Wei Qiao, Regina Abramova, Marina Konopleva, Hagop Kantarjian, Farhad Ravandi, Nicholas Short

Institutions: The University of Texas MD Anderson Cancer Center, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417016719

Cites:

Cited by: 6

Related to: